|1.||Furr, M: 3 articles (06/2006 - 01/2001)|
|2.||Kennedy, T: 3 articles (01/2001 - 01/2001)|
|3.||Gillis, Karen D: 2 articles (03/2008 - 05/2003)|
|4.||Dubey, J P: 2 articles (06/2006 - 01/2006)|
|5.||Mitchell, Sheila M: 2 articles (01/2006 - 06/2004)|
|6.||Lindsay, David S: 2 articles (01/2006 - 06/2004)|
|7.||Zajac, Anne M: 2 articles (01/2006 - 06/2004)|
|8.||Camp, J: 1 article (05/2014)|
|9.||Nichols, J: 1 article (05/2014)|
|10.||Hall, K: 1 article (05/2014)|
06/01/2006 - "Horses were administered ponazuril, once per day, beginning 7 days before infection (study day 0) and continuing for 28 days postinfection. "
06/01/2006 - "These results confirm that treatment with ponazuril at 5.0 mg/kg minimizes, but does not eliminate, infection and clinical signs of EPM in horses."
05/30/2003 - "These results indicate that single-dose administration of ponazuril for prevention of CNS infection is partially protective when given between days 4 and 14 pi."
05/30/2003 - "Ponazuril was administered once, by gavage, at day 1, 3, 7, 10, or 14 post-infection (pi). "
10/18/2002 - "In those calves medicated with ponazuril (one, or six consecutive days, respectively, starting one day after infection), a complete abrogation of the parasite detectability was obtained in the brain and other organs, while 50% of non-treated calves became PCR-positive in brain and muscles. "
05/28/2014 - "The aim of this study was to determine the efficacy of ponazuril paste at each of three dosages (dosage 1, 50mg/kg q24 h for 3 days, dogs n=14, cats n=16; dosage 2, 50mg/kg as a single dose, dogs n=13, cats n=25; or dosage 3, 20mg/kg as a single dose, dogs n=16, cats n=23) in shelter-housed dogs (n=43) and cats (n=64) with confirmed coccidiosis. "
05/28/2014 - "Use of ponazuril paste to treat coccidiosis in shelter-housed cats and dogs."
06/01/2012 - "Ponazuril was not effective at treating besnoitiosis in a naturally infected donkey. "
01/01/2001 - "Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis."
01/01/2001 - "Ponazuril, a triazine-derivative compound, is proposed as a treatment for equine protozoal myeloencephalitis caused by Sarcocystis neurona. "
01/01/2001 - "It was concluded that oral administration of ponazuril to healthy horses at 5 mg/kg provided concentrations of ponazuril in the CSF that are presumed to be adequate for the treatment of equine protozoal myeloencephalitis (EPM). "
06/01/2006 - "The ability of ponazuril to prevent or limit clinical signs of equine protozoal myeloencephalitis (EPM) after infection with Sarcocystis neurona was evaluated. "
06/01/2004 - "The results demonstrate that ponazuril is effective in preventing and treating toxoplasmosis in mice. "
06/01/2004 - "We used outbred female CD-1 mice to determine the efficacy of ponazuril in preventing and treating acute toxoplasmosis. "
06/01/2004 - "Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice."
06/01/2004 - "Sixty percent of mice treated with 10 mg/kg ponazuril at 6 days after infection and 100% of mice treated with 20 mg/kg or 50 mg ponazuril 6 days after infection and then daily for 10 days were protected from fatal toxoplasmosis. "
06/01/2004 - "One hundred percent of mice treated with 10 or 20 mg/kg ponazuril at 3 days after infection and then daily for 10 days were protected from fatal toxoplasmosis. "
|3.||Interferon-gamma (Interferon, gamma)
|1.||Drug Therapy (Chemotherapy)